Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 32 holding rows worth $2,914,193,000.

Accession
0001654954-21-005764
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 32 entries on the cover page, a total value of $2,914,193,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,914,193,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,000,000$396,330,000thousands by filing dateput
CHANGE HEALTHCARE INC15912K100COM11,250,000$248,625,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM3,750,000$205,875,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock1,400,000$186,746,000thousands by filing date
VIATRIS INC COM92556V106Stock12,000,000$167,640,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock3,000,000$156,000,000thousands by filing date
HCA Healthcare Inc40412C101COM775,000$145,964,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock2,800,000$113,316,000thousands by filing date
ALKERMES PLCG01767105SHS5,600,000$104,608,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock625,000$100,050,000thousands by filing date
MYRIAD GENETICS INC62855J104COM3,000,000$91,350,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR2,500,000$89,225,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK7,500,000$83,850,000thousands by filing date
Merck & Co.,Inc.58933Y105COM1,000,000$77,090,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM12,500,000$75,625,000thousands by filing date
Gilead Sciences,Inc.375558103COM1,000,000$64,630,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR5,500,000$63,470,000thousands by filing date
WELLTOWER INC COM95040Q104REIT810,000$58,020,000thousands by filing date
VENTAS INC COM92276F100REIT900,000$48,006,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM2,000,000$47,400,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock1,000,000$44,960,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM3,575,000$41,720,000thousands by filing date
INCYTE CORP COM45337C102Stock500,000$40,635,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM2,000,000$40,000,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A400,000$39,880,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock3,133,333$39,762,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW1,500,000$31,290,000thousands by filing date
BLUEBIRD BIO INC09609G100COM1,000,000$30,150,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK2,555,000$24,835,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM125,000$21,413,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock1,150,000$18,964,000thousands by filing date
INNOVAGE HLDG CORP45784A104COM650,000$16,764,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-21-005764this filing2021-05-17acceptance time not in the bulk data set